SCHEMBL24012260

SCHEMBL24012260

CO[C@@H]1C[C@H](C(=O)Nc2cc(C(N)(CCC3CC3)c3ccccn3)ccc2F)N(C(=O)OC(C)(C)C)C1

nearest known ligand 0.56

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KLKB1 P03952 19/20 0.56
▸ UCHL1 P09936 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24012294 0.92 KLKB1 (0.55) KLKB1
SCHEMBL24569820 0.90 KLKB1 (0.55) KLKB1
SCHEMBL22685022 0.88 KLKB1 (0.56) KLKB1
SCHEMBL20584646 0.87 KLKB1 (0.74) KLKB1
SCHEMBL29581508 0.87 KLKB1 (0.74) KLKB1
SCHEMBL21726714 0.86 KLKB1 (0.45) KLKB1UCHL1
SCHEMBL20584372 0.86 KLKB1 (0.45) KLKB1UCHL1
SCHEMBL20446649 0.86 KLKB1 (0.45) KLKB1UCHL1
SCHEMBL22685920 0.86 KLKB1 (0.45) KLKB1UCHL1
SCHEMBL29489465 0.86 KLKB1 (0.45) KLKB1UCHL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4019022-A1 HUMAN PLASMA KALLIKREIN INHIBITORS BioCryst Pharmaceuticals, Inc. (US) 2022-06-29 — — EP disclosed
EP-3355890-B1 HUMAN PLASMA KALLIKREIN INHIBITORS BIOCRYST PHARM INC (US) 2021-11-10 — — EP disclosed
Send feedback